Similar articles for PMID: 11724447

Year	Number of Results
1998	1
2000	2
2001	4
2002	3
2004	2
2005	5
2006	5
2007	2
2008	8
2009	6
2010	4
2011	3
2012	6
2013	3
2014	3
2015	6
2016	2
2022	2
2024	0

1

Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease.

Spitsin S, Hooper DC, Leist T, Streletz LJ, Mikheeva T, Koprowskil H. Spitsin S, et al. Mult Scler. 2001 Oct;7(5):313-9. doi: 10.1177/135245850100700507. Mult Scler. 2001. PMID: 11724447 Clinical Trial.

2

Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors.

Scott GS, Spitsin SV, Kean RB, Mikheeva T, Koprowski H, Hooper DC. Scott GS, et al. Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16303-8. doi: 10.1073/pnas.212645999. Epub 2002 Nov 25. Proc Natl Acad Sci U S A. 2002. PMID: 12451183 Free PMC article.

3

The treatment of multiple sclerosis with inosine.

Markowitz CE, Spitsin S, Zimmerman V, Jacobs D, Udupa JK, Hooper DC, Koprowski H. Markowitz CE, et al. J Altern Complement Med. 2009 Jun;15(6):619-25. doi: 10.1089/acm.2008.0513. J Altern Complement Med. 2009. PMID: 19425822 Free PMC article. Clinical Trial.

4

Modulation of serum uric acid levels by inosine in patients with multiple sclerosis does not affect blood pressure.

Spitsin S, Markowitz CE, Zimmerman V, Koprowski H, Hooper DC. Spitsin S, et al. J Hum Hypertens. 2010 May;24(5):359-62. doi: 10.1038/jhh.2009.83. Epub 2009 Oct 29. J Hum Hypertens. 2010. PMID: 19865105 Clinical Trial.

5

[Uric acid and multiple sclerosis].

Mattle HP, Lienert C, Greeve I. Mattle HP, et al. Ther Umsch. 2004 Sep;61(9):553-5. doi: 10.1024/0040-5930.61.9.553. Ther Umsch. 2004. PMID: 15493114 Review. German.

6

Serum uric acid levels in patients with multiple sclerosis: a meta-analysis.

Liu B, Shen Y, Xiao K, Tang Y, Cen L, Wei J. Liu B, et al. Neurol Res. 2012 Mar;34(2):163-71. doi: 10.1179/1743132811Y.0000000074. Epub 2012 Jan 31. Neurol Res. 2012. PMID: 22333889

7

Therapeutic value of serum uric acid levels increasing in the treatment of multiple sclerosis.

Toncev G. Toncev G. Vojnosanit Pregl. 2006 Oct;63(10):879-82. doi: 10.2298/vsp0610879t. Vojnosanit Pregl. 2006. PMID: 17121380 Clinical Trial.

8

Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis.

Dujmovic I, Pekmezovic T, Obrenovic R, Nikolić A, Spasic M, Mostarica Stojkovic M, Drulovic J. Dujmovic I, et al. Clin Chem Lab Med. 2009;47(7):848-53. doi: 10.1515/CCLM.2009.192. Clin Chem Lab Med. 2009. PMID: 19496733

9

Serum uric acid and multiple sclerosis.

Rentzos M, Nikolaou C, Anagnostouli M, Rombos A, Tsakanikas K, Economou M, Dimitrakopoulos A, Karouli M, Vassilopoulos D. Rentzos M, et al. Clin Neurol Neurosurg. 2006 Sep;108(6):527-31. doi: 10.1016/j.clineuro.2005.08.004. Epub 2005 Oct 3. Clin Neurol Neurosurg. 2006. PMID: 16202511

10

Serum uric acid and multiple sclerosis.

Sotgiu S, Pugliatti M, Sanna A, Sotgiu A, Fois ML, Arru G, Rosati G. Sotgiu S, et al. Neurol Sci. 2002 Oct;23(4):183-8. doi: 10.1007/s100720200059. Neurol Sci. 2002. PMID: 12536287 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year